| Literature DB >> 12481944 |
Angela M Inzerillo1, Mone Zaidi, Christopher L H Huang.
Abstract
Calcitonin was originally discovered as a hypocalcemic factor synthesized by thyroid parafollicular C cells. Early experiments demonstrated that calcitonin inhibited bone resorption and decreased calcium efflux from isolated cat tibiae and subsequent histologic and culture studies confirmed the osteoclast as its major site of action. Its potent antiresorptive effect and analgesic action have led to its clinical use in treatment of Paget's bone disease, osteoporosis, and hypercalcemia of malignancy. This review surveys the cellular and molecular basis of these physiologic and clinical actions.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12481944 DOI: 10.1089/105072502760339352
Source DB: PubMed Journal: Thyroid ISSN: 1050-7256 Impact factor: 6.568